PUBLIC CONTRACT · 2025
Medicamento bictegravir emtricitabina tenofovir alafenamida cp. 50+200+25mg ao abrigo do CP 2024/900 dos SPMS
- Contract value
- €2,325,456.00
- Signed on
- 27 November 2025
- Procedure
- Ao abrigo de acordo-quadro (art.º 258.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 12168513PUBLISHED SUBJECT
Medicamento bictegravir emtricitabina tenofovir alafenamida cp. 50+200+25mg ao abrigo do CP 2024/900 dos SPMS
Parties involved
- Place of performance
- Portugal, Porto, Porto
- NUTS region
- PT11A - Área Metropolitana do Porto
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- GILEAD SCIENCES, LDA. · Tax ID 503604704
Values and timeline
- Contract price
- €2,325,456.00
- Procedure base price
- €2,325,456.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 20 December 2025
- Award date
- 27 November 2025
- Signing date
- 27 November 2025
- Performance period
- 31 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 258.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 258.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 111-B/2017 ) e DLR no 34/2008/M, de 14.08 (DLR n.º 6/2018/M)
- Framework agreement
- CP 2022/40 - Medicamentos antirretrovíricos para o tratamento da infeção por VIH
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 8254249
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.